GlassScriptPhysician profile
Lani M Warren
NPI 1497831887
$3,719.47
in general payments reported to CMS, 2019-2025
30 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $467 · 2021: $707 · 2022: $541 · 2023: $649 · 2024: $364 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,290.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $816.53 | 2019-2025 | Wegovy |
| Abbvie INC. | $655.57 | 2019-2023 | Liletta |
| Astellas Pharma US INC | $287.51 | 2023-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $231.65 | 2021-2022 | |
| Lupin INC. | $200.15 | 2019-2021 | |
| Therapeuticsmd, INC. | $174.91 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $169.58 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.40 | 2019-2023 | |
| Organon LLC | $124.26 | 2021-2024 | Nexplanon |
| Avion Pharmaceuticals | $103.75 | 2019-2022 | |
| Exeltis, USA INC. | $93.86 | 2021-2023 | Slynd |
| Merz North America, INC. | $81.81 | 2019 | |
| Myriad Women'S Health, INC. | $73.98 | 2023 | Myrisk |
| Aspira Women'S Health INC | $73.53 | 2022-2023 | Ova1 |
| Merck Sharp & Dohme LLC | $57.91 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $52.27 | 2021-2022 | |
| Biogen, INC. | $52.08 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $49.57 | 2023 | Myfembree |
| Optumhealth Care Solutions, LLC | $41.76 | 2023 | Vivify Health Care Team Portal |
| Vertical Pharmaceuticals, LLC | $34.88 | 2019 | |
| Mission Pharmacal Company | $32.59 | 2019 | |
| Allergan, INC. | $29.98 | 2020 | |
| Alydia Health | $21.99 | 2021 | |
| Minerva Surgical, INC | $20.29 | 2021 | |
| Lilly USA, LLC | $18.82 | 2025 | Zepbound |
| Mycovia Pharmaceuticals, INC. | $17.65 | 2023 | Vivjoa |
| Innovation Technologies INC | $16.53 | 2025 | Irrisept |
| Millicent US INC | $15.80 | 2024 | Intrarosa, Femring |
| Covidien LP | $14.93 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lani Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.